Investor Granite Point Capital Management, L.P.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Granite Point Capital Management, L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2022-01-26 13G/A STIM / Neuronetics, Inc. 1,246,782 0
2021-02-12 13G/A SIEN / Sientra, Inc. 2,986,581 2,396,000
2021-02-12 13G/A STIM / Neuronetics, Inc. 1,300,000 1,246,782
2020-10-07 13G SIEN / Sientra, Inc. 2,986,581
2020-09-18 13G STIM / Neuronetics, Inc. 1,300,000
2020-01-27 13G/A MRNS / Marinus Pharmaceuticals, Inc. 4,259,367 2,700,000
2019-01-23 13G/A MRNS / Marinus Pharmaceuticals, Inc. 2,278,848 4,259,367
2018-01-11 13G/A MRNS / Marinus Pharmaceuticals, Inc. 2,184,848 2,278,848
2017-07-18 13G MRNS / Marinus Pharmaceuticals, Inc. 2,184,848